Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mozobil Monotherapy for PBPC Mobilization in Multiple Myeloma
NCT00396383Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Nov 2004
- Primary completion
- May 2007
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in multiple myeloma (MM), sponsored by Sanofi. Started Nov 2004; status: terminated.
02
Drugs
plerixafor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00396383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396383.